China granted the world’s first regulatory approval of a gene therapy product
In 2003, China granted the world’s first regulatory approval of a gene therapy product, Gendicine (Shenzhen SiBiono GenTech),…
In 2003, China granted the world’s first regulatory approval of a gene therapy product, Gendicine (Shenzhen SiBiono GenTech),…
In 2002, Stanford geneticist Mark Kay uses a gene-therapy technique known as RNA inhibition to switch off genes…
On Jan. 11, 2001, Oregon Health Sciences University (OHSU) researchers reported the production of the world’s first genetically…
On Oct. 25, 1996, the first gene therapy trial for patients with Hunter syndrome was begun at the…
In 1995, Gene therapy, immune-system modulation and recombinantly produced antibodies enter the clinic in the war against cancer….
In 1993, Targeted Genetics, a subsidiary of the Immunex Corporation, became the first company to begin human clinical…
In 1992, the University of Iowa (UI) Research Foundation received its first U.S. patent on the CMV promoter,…
On Sept. 14, 1990, W. French Anderson and his colleagues at the National Institutes of Health (NIH) performed…
On May 22, 1989, Dr. Steven A. Rosenberg and his team at the National Cancer Institute (NCI) performed…
On Jan. 1, 1989, Targeted Genetics, an Immunex Corp. spin-off in Seattle. which specialized in gene therapy, a…
In 1973, UChicago established the University of Chicago Comprehensive Cancer Center (UCCCC), receiving its initial designation as a…
In 1971, the University of Alabama at Birmingham Comprehensive Cancer Center (UAB) was founded and received its NCI…